Kirti Saxena

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder
    Kirti Saxena
    Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, School of Medicine, Stanford University, 401 Quarry Road, Stanford, CA 94305, USA
    J Child Adolesc Psychopharmacol 16:252-9. 2006
  2. ncbi Baseline predictors of response to divalproex in conduct disorder
    Kirti Saxena
    Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305, USA
    J Clin Psychiatry 66:1541-8. 2005
  3. ncbi Divalproex sodium in the treatment of pediatric psychiatric disorders
    Manasi Rana
    Division of Child Psychiatry and Child Development, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
    Expert Rev Neurother 5:165-76. 2005
  4. ncbi An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression
    Kiki Chang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5540, USA
    J Am Acad Child Adolesc Psychiatry 45:298-304. 2006
  5. ncbi Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder
    Kiki D Chang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5540, USA
    J Child Adolesc Psychopharmacol 20:25-32. 2010
  6. ncbi Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial
    Hans Steiner
    Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
    J Clin Psychiatry 64:1183-91. 2003
  7. ncbi Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series
    Kirti Saxena
    Department of Psychiatry, Stanford University, Palo Alto, CA 94305, USA
    Bipolar Disord 8:405-10. 2006
  8. ncbi Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder
    Leena A Khanzode
    Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
    Child Psychiatry Hum Dev 37:55-64. 2006
  9. ncbi Psychopharmacologic strategies for the treatment of aggression in juveniles
    Hans Steiner
    Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, Stanford University School of Medicine, California 94503, USA
    CNS Spectr 8:298-308. 2003
  10. ncbi Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda
    Daniel F Connor
    Department of Psychiatry MC1410, University of Connecticut Health Center, Farmington 06030 1410, USA
    J Clin Psychiatry 67:808-20. 2006

Detail Information

Publications10

  1. ncbi Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder
    Kirti Saxena
    Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, School of Medicine, Stanford University, 401 Quarry Road, Stanford, CA 94305, USA
    J Child Adolesc Psychopharmacol 16:252-9. 2006
    ..The psychopharmacology of aggression in youth is relatively unexplored, even though such maladaptive aggression manifests across many different diagnoses...
  2. ncbi Baseline predictors of response to divalproex in conduct disorder
    Kirti Saxena
    Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305, USA
    J Clin Psychiatry 66:1541-8. 2005
    ....
  3. ncbi Divalproex sodium in the treatment of pediatric psychiatric disorders
    Manasi Rana
    Division of Child Psychiatry and Child Development, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
    Expert Rev Neurother 5:165-76. 2005
    ..In this drug profile, divalproex sodium and its uses in the pediatric population for psychiatric conditions are reviewed...
  4. ncbi An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression
    Kiki Chang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305 5540, USA
    J Am Acad Child Adolesc Psychiatry 45:298-304. 2006
    ..The authors wished to prospectively study the efficacy of lamotrigine as adjunctive or monotherapy in adolescents with bipolar disorder who were experiencing a depressive episode...
  5. ncbi Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder
    Kiki D Chang
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305 5540, USA
    J Child Adolesc Psychopharmacol 20:25-32. 2010
    ..We sought to describe psychotropic medication exposure in a cohort of children at risk for BD and retrospectively determine the effect of medication exposure on age at onset (AAO) of BD...
  6. ncbi Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial
    Hans Steiner
    Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
    J Clin Psychiatry 64:1183-91. 2003
    ..New treatments for conduct disorder are sorely needed. We aimed to test the efficacy of divalproex sodium for the treatment of conduct disorder...
  7. ncbi Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series
    Kirti Saxena
    Department of Psychiatry, Stanford University, Palo Alto, CA 94305, USA
    Bipolar Disord 8:405-10. 2006
    ..To evaluate the effectiveness and safety of risperidone in children and adolescents with bipolar disorder characterized by aggression and mania, despite treatment with mood stabilizers...
  8. ncbi Efficacy profiles of psychopharmacology: divalproex sodium in conduct disorder
    Leena A Khanzode
    Division of Child Psychiatry and Child Development, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA 94305 5719, USA
    Child Psychiatry Hum Dev 37:55-64. 2006
    ..This is a rare clinical trial, which provides preliminary evidence for the different profiles of efficacy of medication treatment...
  9. ncbi Psychopharmacologic strategies for the treatment of aggression in juveniles
    Hans Steiner
    Department of Psychiatry and Behavioral Sciences, Division of Child Psychiatry and Child Development, Stanford University School of Medicine, California 94503, USA
    CNS Spectr 8:298-308. 2003
    ....
  10. ncbi Juvenile maladaptive aggression: a review of prevention, treatment, and service configuration and a proposed research agenda
    Daniel F Connor
    Department of Psychiatry MC1410, University of Connecticut Health Center, Farmington 06030 1410, USA
    J Clin Psychiatry 67:808-20. 2006
    ..To propose a research agenda for disorders of aggression in child and adolescent psychiatry...